Patents by Inventor Changlu Liu

Changlu Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11885292
    Abstract: A tidal current energy generating device includes a generator, a connecting shaft, an impeller and an adjustment assembly. The impeller includes an impeller hub and an impeller blade arranged thereon. The impeller hub is connected with the connecting shaft, and the generator is connected with the impeller hub. The impeller blade is driven under the action of a tidal current to drive the impeller hub to rotate synchronously around an axis of the connecting shaft, driving the generator to generate electricity. The adjustment assembly is connected with the impeller blade, and can be driven to swing under the action of the tidal current to drive the impeller blade to rotate around the axis of the impeller blade relative to the impeller hub, thereby adjusting the angle of the impeller blade.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: January 30, 2024
    Assignee: HangZhou JiangHe Hydro-Electrical Science & Technology Co., Ltd.
    Inventors: Changlu Liu, Xueming Zhang, Zhengming Zhou, Liwei Chen, Wanqiang Zhu, Jinbo Hu, Jianmei Chen, Yinhua Chen, Yongjun Dong, Shanguo Peng, Zhumei Fang, Panhua Ning
  • Publication number: 20220125898
    Abstract: Provided herein are methods of identifying an agent that activates a protease-activated receptor 2 (PAR2)intracellularly. Also provided are isolated mutant PAR2 polypeptides, isolated polynucleotides encoding the mutant PAR2 polypeptides, vectors comprising the isolated polynucleotides, and host cells comprising the vectors.
    Type: Application
    Filed: April 30, 2020
    Publication date: April 28, 2022
    Applicant: JANSSEN BIOTECH, INC.
    Inventors: Changlu LIU, Siquan SUN, Grace STEEMERS-LEE, Belinda LIU
  • Publication number: 20220082076
    Abstract: A tidal current energy generating device includes a generator, a connecting shaft, an impeller and an adjustment assembly. The impeller includes an impeller hub and an impeller blade arranged thereon. The impeller hub is connected with the connecting shaft, and the generator is connected with the impeller hub. The impeller blade is driven under the action of a tidal current to drive the impeller hub to rotate synchronously around an axis of the connecting shaft, driving the generator to generate electricity. The adjustment assembly is connected with the impeller blade, and can be driven to swing under the action of the tidal current to drive the impeller blade to rotate around the axis of the impeller blade relative to the impeller hub, thereby adjusting the angle of the impeller blade.
    Type: Application
    Filed: November 23, 2021
    Publication date: March 17, 2022
    Inventors: Changlu LIU, Xueming ZHANG, Zhengming ZHOU, Liwei CHEN, Wanqiang ZHU, Jinbo HU, Jianmei CHEN, Yinhua CHEN, Yongjun DONG, Shanguo PENG, Zhumei FANG, Panhua NING
  • Patent number: 11060500
    Abstract: The present invention discloses a ducted bidirectional tidal current power station system, mainly consisting of a bidirectional tidal current power generation device, a dam, an open sea, an inland sea, a duct, and an opening/closing gate. The bidirectional tidal current power generation device is installed in the duct on the bottom of the dam. Openings, respectively communicated with the open sea and the inland sea, are formed at two ends of the duct, and an opening/closing gate is arranged at each of the two openings. By the ducted bidirectional tidal current power station system of the present invention, the cost of marine construction, operation and maintenance of the tidal current power generation device in an open sea area is saved, and the complex structure of the power generation device in the tidal power station and the cost of strict construction of auxiliary devices and runners are avoided.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: July 13, 2021
    Assignee: HangZhou JiangHe Hydro-Electrical Sci. & Tech. Co.
    Inventors: Liwei Chen, Changlu Liu, Jianfeng Yu, Dongli Zhang, Yinhua Chen, Qianqian Li, Yujuan Wang, Jinbo Hu
  • Patent number: 11028820
    Abstract: A tidal current generating unit, including a turbine, a hub, a generator, a bearing set and a fixed flange. The turbine is connected to the rotor of the generator through the hub, and the rotor is rotatably mounted on the outer circumference of the stator of the generator via the bearing set, and the turbine drives the rotating component to rotate to generate electricity. A density of a blade is much smaller than a density of the seawater, such that the blade has a sufficient buoyancy that offsets the gravity of the rotating component in seawater, and the load of the bearing sets is reduced. The blade is a backswept blade and the hydrodynamic central axis of the blade is inclined from a flange central axis of the blade at a first angle, and the blade is able to automatically change the pitch without relying on an external force.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: June 8, 2021
    Assignee: HangZhou JiangHe Hydro-Electrical Science & Technolo
    Inventors: Changlu Liu, Liwei Chen, Zhengming Zhou, Jianfeng Yu, Yinhua Chen, Shanguo Peng, Junsheng Wei, Xue Sun, Chunming Zhao, Yongzhen Cheng, Fang Wang
  • Publication number: 20210108607
    Abstract: A tidal current generating unit, including a turbine, a hub, a generator, a bearing set and a fixed flange. The turbine is connected to the rotor of the generator through the hub, and the rotor is rotatably mounted on the outer circumference of the stator of the generator via the bearing set, and the turbine drives the rotating component to rotate to generate electricity. A density of a blade is much smaller than a density of the seawater, such that the blade has a sufficient buoyancy that offsets the gravity of the rotating component in seawater, and the load of the bearing sets is reduced. The blade is a backswept blade and the hydrodynamic central axis of the blade is inclined from a flange central axis of the blade at a first angle, and the blade is able to automatically change the pitch without relying on an external force.
    Type: Application
    Filed: November 19, 2019
    Publication date: April 15, 2021
    Inventors: Changlu LIU, Liwei Chen, Zhengming Zhou, Jianfeng Yu, Yinhua Chen, Shanguo Peng, Junsheng Wei, Xue Sun, Chunming Zhao, Yongzhen Cheng, Fang Wang
  • Publication number: 20200132041
    Abstract: The present invention discloses a ducted bidirectional tidal current power station system, mainly consisting of a bidirectional tidal current power generation device, a dam, an open sea, an inland sea, a duct, and an opening/closing gate. The bidirectional tidal current power generation device is installed in the duct on the bottom of the dam. Openings, respectively communicated with the open sea and the inland sea, are formed at two ends of the duct, and an opening/closing gate is arranged at each of the two openings. By the ducted bidirectional tidal current power station system of the present invention, the cost of marine construction, operation and maintenance of the tidal current power generation device in an open sea area is saved, and the complex structure of the power generation device in the tidal power station and the cost of strict construction of auxiliary devices and runners are avoided.
    Type: Application
    Filed: August 30, 2019
    Publication date: April 30, 2020
    Inventors: Liwei CHEN, Changlu LIU, Jianfeng YU, Dongli ZHANG, Yinhua CHEN, Qianqian LI, Yujuan WANG, Jinbo HU
  • Publication number: 20160022636
    Abstract: Provided herein are compounds capable of activating GPR139. Also provided are methods of increasing and decreasing the activity of GPR139. Methods of using the identified compounds to modulate GPR139 activity or conditions that may be affected by GPR139 activity are also disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Curt A. DVORAK, Changlu LIU, Chester KUEI
  • Publication number: 20140336216
    Abstract: Provided herein are compounds capable of activating GPR139. Also provided are methods of increasing and decreasing the activity of GPR139. Methods of using the identified compounds to modulate GPR139 activity or conditions that may be affected by GPR139 activity are also disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: November 13, 2014
    Applicant: Janssen Pharmaceutica NV
    Inventors: Curt A. Dvorak, Changlu Liu, Chester Kuei
  • Patent number: 8299028
    Abstract: The chimeric polypeptide R3(B?23-27)R/I5 is described, which is a high-affinity antagonist for GPCR1 35 and GPCR1 42 over LGR7.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: October 30, 2012
    Assignee: Janssen Pharmaceutica NV
    Inventors: Chester Kuei, Changlu Liu, Cindy M. Pudiak, Jonathan Edward Shelton, Steven W. Sutton
  • Patent number: 8148056
    Abstract: Complexes of GPR81 receptor components and ligand components, such as L-lactate or GHB, may be used as an assay reagent for screening for modulators of GPR81 receptor activity.
    Type: Grant
    Filed: April 1, 2008
    Date of Patent: April 3, 2012
    Assignee: Janssen Pharmaceutica NV
    Inventors: Changlu Liu, Timothy W. Lovenberg, Jiejun Wu
  • Publication number: 20110104711
    Abstract: Complexes of GPR81 receptor components and ligand components, such as L-lactate or GHB, may be used as an assay reagent for screening for modulators of GPR81 receptor activity.
    Type: Application
    Filed: April 1, 2008
    Publication date: May 5, 2011
    Inventors: Changlu Liu, Timothy W. Lovenberg, Jiejun Wu
  • Patent number: 7893197
    Abstract: Chimeric polypeptides of relaxin-3, prepropolypeptides thereof, polynucleotides encoding such polypeptides, and associated expression vectors and host cells are described. The polypeptides may be used to prepare receptor-ligand complexes with GPCR135 or GPCR142, which may be used in assay methods.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: February 22, 2011
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Pascal Bonaventure, Chester Kuei, Changlu Liu, Timothy W. Lovenberg, Steven W. Sutton
  • Publication number: 20100145007
    Abstract: The chimeric polypeptide R3(B?23-27)R/I5 is described, which is a high-affinity antagonist for GPCR1 35 and GPCR1 42 over LGR7.
    Type: Application
    Filed: January 23, 2008
    Publication date: June 10, 2010
    Inventors: Chester Kuei, Changlu Liu, Cindy M. Pudiak, Jonathan Shelton, Steven W. Sutton
  • Patent number: 7728107
    Abstract: Canine 5-hydroxytryptamine 2 receptor materials are described, including polypeptides corresponding to SEQ ID NOs.:8 and 10 and polynucleotides expressing them corresponding to SEQ ID NOs.:7 and 9. Such materials are useful as reagents in drug screening assays to identify compounds having 5-HT2 receptor-modulating activity.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: June 1, 2010
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Pascal Bonaventure, Changlu Liu, Timothy W. Lovenberg, Diane Nepomuceno
  • Patent number: 7612163
    Abstract: A PK2? peptide is described, which, as an agonist of prokineticin receptor 1, is useful for treating lung and gastrointestinal diseases or disorders mediated by PKR1 activity.
    Type: Grant
    Filed: March 29, 2005
    Date of Patent: November 3, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Changlu Liu, Jingcai Chen
  • Publication number: 20080131913
    Abstract: Canine 5-hydroxytryptamine 2 receptor materials are described, including polypeptides corresponding to SEQ ID NOs:8 and 10 and polynucleotides expressing them corresponding to SEQ ID NOs:7 and 9. Such materials are useful as reagents in drug screening assays to identify compounds having 5-HT2 receptor-modulating activity.
    Type: Application
    Filed: January 13, 2006
    Publication date: June 5, 2008
    Inventors: Pascal Bonaventure, Changlu Liu, Timothy W. Lovenberg, Diane Nepomuceno
  • Publication number: 20080051336
    Abstract: Chimeric polypeptides of relaxin-3, prepropolypeptides thereof, polynucleotides encoding such polypeptides, and associated expression vectors and host cells are described. The polypeptides may be used to prepare receptor-ligand complexes with GPCR135 or GPCR142, which may be used in assay methods.
    Type: Application
    Filed: August 25, 2005
    Publication date: February 28, 2008
    Inventors: Pascal Bonaventure, Chester Kuei, Changlu Liu, Timothy Lovenberg, Steven Sutton
  • Patent number: 7202057
    Abstract: DNAs encoding the mammalian histamine H4 receptors have been cloned and characterized. These recombinant molecules are capable of expressing biologically active histamine H4 receptor protein. The cDNA's have been expressed in recombinant host cells that produce active recombinant protein. The pharmacology of known histamine ligands is demonstrated. The recombinant protein may be purified from the recombinant host cells. In addition, recombinant host cells are utilized to establish methods to identify modulators of the receptor activity, and receptor modulators are identified.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: April 10, 2007
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Timothy Lovenberg, Changlu Liu
  • Patent number: 7183078
    Abstract: DNAs encoding the mammalian histamine H4 receptors have been cloned and characterized. These recombinant molecules are capable of expressing biologically active histamine H4 receptor protein. The cDNA's have been expressed in recombinant host cells that produce active recombinant protein. The pharmacology of known histamine ligands is demonstrated. The recombinant protein may be purified from the recombinant host cells. In addition, recombinant host cells are utilized to establish methods to identify modulators of the receptor activity, and receptor modulators are identified.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: February 27, 2007
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Timothy Lovenberg, Changlu Liu